-
00:00
1.
index 1
-
02:03
2.
** after 20230109.pptx
-
02:15
3.
Slide 21
-
02:48
4.
** after 20230109.pptx
-
02:54
5.
Slide 1
-
05:16
6.
CircRNA-CREIT was downregulated in TNBC
-
08:50
7.
CircRNA-CREIT was downregulated in TNBC
-
20:55
8.
CircRNA-CREIT was downregulated in TNBC
-
21:29
9.
The biogenesis of circRNA-CREIT was inhibited by DHX9
-
23:37
10.
The biogenesis of circRNA-CREIT was inhibited by DHX9
-
24:14
11.
CircRNA-CREIT significantly enhanced the chemosensitivity of TNBC cells in vitro and in vivo
-
35:40
12.
CircRNA-CREIT significantly enhanced the chemosensitivity of TNBC cells in vitro and in vivo
-
41:19
13.
CircRNA-CREIT significantly enhanced the chemosensitivity of TNBC cells in vitro and in vivo
-
45:51
14.
CircRNA-CREIT physically interacted with PKR
-
52:18
15.
CircRNA-CREIT physically interacted with PKR
-
52:19
16.
CircRNA-CREIT physically interacted with PKR
-
52:39
17.
CircRNA-CREIT physically interacted with PKR
-
55:20
18.
CircRNA-CREIT physically interacted with PKR
-
55:22
19.
CircRNA-CREIT physically interacted with PKR
-
56:40
20.
CircRNA-CREIT physically interacted with PKR
-
1:00:01
21.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
1:03:51
22.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
1:04:30
23.
Ubiquitin–proteasome system
-
1:05:52
24.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
1:06:45
25.
Ubiquitin–proteasome system
-
1:06:49
26.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
1:07:04
27.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
1:07:54
28.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
1:08:27
29.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
1:09:00
30.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
1:09:01
31.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
1:09:37
32.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
1:11:24
33.
Slide 21
-
1:12:16
34.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
1:13:08
35.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
1:14:37
36.
Slide 24
-
1:14:44
37.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
1:14:47
38.
Slide 24
-
1:15:20
39.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
1:17:14
40.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
1:19:42
41.
ISRIB exerted synergistic roles with circRNA-CREIT in improving chemosensitivity of TNBC cells
-
1:20:55
42.
ISRIB exerted synergistic roles with circRNA-CREIT in improving chemosensitivity of TNBC cells
-
1:21:20
43.
ISRIB exerted synergistic roles with circRNA-CREIT in improving chemosensitivity of TNBC cells
-
1:21:27
44.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:22:55
45.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:23:24
46.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:23:25
47.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:23:41
48.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:24:09
49.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:25:21
50.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:25:24
51.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:26:29
52.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
1:34:39
53.
Conclusion